When Vivian Kneller was an infant, her pediatrician told her parents that they needed to take her from their home in Knoxville, Tennessee, to an eye specialist in Nashville. That doctor told them to ...

COLORADO SPRINGS, Colo. — The evolution of retinoblastoma treatment over the past 15 years has resulted in a higher likelihood of vision preservation without compromising survival, according to ...

A shorter regimen of three cycles of adjuvant chemotherapy was noninferior to a standard six-cycle regimen among patients with pathologically high-risk retinoblastoma, a Chinese randomized trial ...

Please provide your email address to receive an email when new articles are posted on . Fewer adjuvant chemotherapy cycles benefited infants with unilateral pathologic high-risk retinoblastoma. Six ...

Three cycles of chemotherapy showed similar efficacy to six cycles in preventing metastasis and death in high-risk retinoblastoma. The study reported fewer side effects and a lesser decline in quality ...

Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols Purpose: To evaluate the efficacy of chemoreduction using ...

A significant area of concern surrounding these statistics is eye cancer. There are a few forms of eye cancer which are commonly found in children. These include Retinoblastoma, Uveal Melanoma, ...

ROCKVILLE, Md., July 31, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics, Inc. (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related ...

The evolution of retinoblastoma treatment over the past 15 years has resulted in a higher likelihood of vision preservation without compromising survival, according to research released today at the ...

Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to be presented in an invited session at the 41st Asia-Pacific Academy of ...